published meta-analysis   sensitivity analysis   studies

neutralizing antibody in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsRECOVERY (REGN-COV2), 2021 0.80 [0.70; 0.91] 0.80[0.70; 0.91]RECOVERY (REGN-COV2), 202110%3,153NAnot evaluable deathsdetailed resultsRECOVERY (REGN-COV2), 2021 0.80 [0.70; 0.91] 0.80[0.70; 0.91]RECOVERY (REGN-COV2), 202110%3,153NAnot evaluable death or ventilationdetailed resultsRECOVERY (REGN-COV2), 2021 0.83 [0.75; 0.92] 0.83[0.75; 0.92]RECOVERY (REGN-COV2), 202110%3,083NAnot evaluable hospital dischargedetailed resultsRECOVERY (REGN-COV2), 2021 1.19 [1.08; 1.31] 1.19[1.08; 1.31]RECOVERY (REGN-COV2), 202110%3,153NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-04-30 18:36 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 729,887,742,878,975,570,771,888,1141,690,880,1255 - roots T: 290